Aldeyra Therapeutics
2 followers
‌
Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.
Industries
Headquarters
Employees
Links
Org chart
Todd C. Brady
CEO & President
Todd C. Brady
Collapse
Christopher Pearson
Vice President, Commercial Development and Strategy
David J. Clark
Chief Medical Officer
David Noskowitz
Vice President, Regulatory Affairs
Lise L. Kjems
Vice President, Clinical Development
Stephen G. Machatha
Senior Vice President, Technical Operations
Bruce Greenberg
Senior Vice President Of Finance, Interim Cfo, And Treasurer
Nate Hornbach
Sr. Director, Market Access
